Galán Santiago, de la Vega Rocío, Esteve Rosa, López-Martínez Alicia E, Fernández Baena Mariano, Ramírez-Maestre Carmen
Instituto de Investigación Biomédica de Málaga (IBIMA Plataforma BIONAND), Málaga, Spain.
Red de Investigación en Cronicidad, Atención Primaria y Prevención y Promoción de la Salud (RICAPPS), Málaga, Spain.
Front Pain Res (Lausanne). 2023 Oct 19;4:1269018. doi: 10.3389/fpain.2023.1269018. eCollection 2023.
Opioids are being prescribed widely, and increasingly, for the treatment of chronic non-cancer pain (CNCP). However, several side effects are associated with mid- and long-term opioid use and, for certain patients, with the risk of problematic opioid use. The aim of this study is to know the perception of the physicians about which variables could be associated with increased risk of patients with CNCP developing a problem of abuse or misuse of the prescribed opioid medication.
Twenty-nine physicians with experience in CNCP pain management and opioids prescription participated in a two-round Delphi study focused on the risk factors for opioid misuse and abuse.
The variables that reached consensus regarding their relationship with the increased risk of suffering a problem of opioid abuse or misuse were: (1) Experiencing pain on a daily basis, (2) previous use of high-dose opioids, (3) generalized anxiety, (4) hopelessness, (5) benzodiazepine intake, (6) use of opioids for reasons other than pain, (7) family problems, family instability or family breakdown, and (8) having access to several opioid prescribers. The only variable that reached consensus regarding it not being associated to a possible risk of abuse or misuse was having mild pain intensity (0-4 on a NRS-11).
This study provides useful information that could help make decisions about the use of opioids for CNCP treatment and prevent future difficulties. Prospective studies testing the relationship of the variables that reached consensus with the risk of opioid misuse and abuse are warranted.
This study shows the variables of CNCP that the professional must take into account in order to avoid possible problems when prescribing opioids.
阿片类药物被广泛且越来越多地用于治疗慢性非癌性疼痛(CNCP)。然而,中长期使用阿片类药物会带来多种副作用,并且对某些患者而言,存在阿片类药物使用问题的风险。本研究的目的是了解医生对于哪些变量可能与CNCP患者滥用或误用所开阿片类药物风险增加相关的看法。
29名有CNCP疼痛管理和阿片类药物处方经验的医生参与了一项两轮德尔菲研究,该研究聚焦于阿片类药物滥用和误用的风险因素。
就其与阿片类药物滥用或误用风险增加的关系达成共识的变量有:(1)每天都经历疼痛,(2)既往使用过高剂量阿片类药物,(3)广泛性焦虑,(4)绝望感,(5)服用苯二氮䓬类药物,(6)因疼痛以外的原因使用阿片类药物,(7)家庭问题、家庭不稳定或家庭破裂,以及(8)能接触到多位阿片类药物开处方者。就其与可能的滥用或误用风险无关达成共识的唯一变量是疼痛强度较轻(数字评定量表-11为0至4)。
本研究提供了有用信息,有助于在使用阿片类药物治疗CNCP时做出决策并预防未来出现问题。有必要进行前瞻性研究,检验达成共识的变量与阿片类药物滥用和误用风险之间的关系。
本研究显示了在开具阿片类药物处方时专业人员为避免可能出现的问题必须考虑的CNCP变量。